Publications:

Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cancer cells.

Npj Breast Cancer

Hancock, G R GR; Young, K S KS; Hosfield, D J DJ; Joiner, C C; Sullivan, E A EA; Yildiz, Y Y; Lainé, M M; Greene, G L GL; Fanning, S W SW

Publication Date: 2022-12-14

Variant appearance in text: ESR1: C381S

PubMed Link: 36517522

Variant Present in the following documents:

• Main text
• 41523_2022_Article_497.pdf

View BVdb publication page

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: ESR1: 1142G>C; C381S

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 3
• Table_2.xlsx, sheet 2

View BVdb publication page

Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells.

Elife

Hosfield, David J DJ; Weber, Sandra S; Li, Nan-Sheng NS; Sauvage, Madline M; Joiner, Carstyn F CF; Hancock, Govinda R GR; Sullivan, Emily A EA; Ndukwe, Estelle E; Han, Ross R; Cush, Sydney S; Lainé, Muriel M; Mader, Sylvie C SC; Greene, Geoffrey L GL; Fanning, Sean W SW

Publication Date: 2022-05-16

Variant appearance in text: ESR1: C381S

PubMed Link: 35575456

Variant Present in the following documents:

• Main text
• elife-72512.pdf

View BVdb publication page

Computer-Aided Ligand Discovery for Estrogen Receptor Alpha.

International Journal Of Molecular Sciences

Bafna, Divya D; Ban, Fuqiang F; Rennie, Paul S PS; Singh, Kriti K; Cherkasov, Artem A

Publication Date: 2020-06-12

Variant appearance in text: ESR1: C381S

PubMed Link: 32545494

Variant Present in the following documents:

• Main text
• ijms-21-04193.pdf

View BVdb publication page

Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity.

Nature Communications

Fanning, S W SW; Hodges-Gallagher, L L; Myles, D C DC; Sun, R R; Fowler, C E CE; Plant, I N IN; Green, B D BD; Harmon, C L CL; Greene, G L GL; Kushner, P J PJ

Publication Date: 2018-06-18

Variant appearance in text: ESR1: C381S

PubMed Link: 29915250

Variant Present in the following documents:

• 41467_2018_Article_4413.pdf

View BVdb publication page